FAQ/Help |
Calendar |
Search |
Today's Posts |
10-12-2012, 08:12 AM | #1 | ||
|
|||
Magnate
|
Impax Pharmaceuticals Announces Extension of RytaryTM FDA Review Date to January 21, 2013
http://finance.yahoo.com/news/impax-...120000996.html |
||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
IPX066 Open Label Extension Study | Parkinson's Disease Clinical Trials | |||
IPX066, Phase III results | Parkinson's Disease Clinical Trials | |||
APEX-PD Phase III Trial of IPX066 in Parkinson's Disease, older news | Parkinson's Disease | |||
IPX066 for PD: who has the lastest? | Parkinson's Disease | |||
Impax Pharmaceuticals: Phase III trial of IPX066 in Parkinson’s Disease | Parkinson's Disease Clinical Trials |